Sebia announces acquisition of ORGENTEC Diagnostika
Acquisition30/06/2021
Sebia announced an agreement to acquire ORGENTEC Diagnostika from Water Street Healthcare Partners. The acquired diagnostics business included Corgenix and AROTEC and expanded Sebia’s autoimmune and infectious-disease offering. The June 2021 release expected completion in the following quarter; Sebia’s October 2022 release subsequently confirmed the 2021 acquisitions. Financial terms were undisclosed.
Type
Acquisition
Announced
30/06/2021
Amount
Financial data requires access
Reported parties
Sebia; ORGENTEC Diagnostika; Water Street Healthcare Partners